Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 21747310)

Published in Pancreas on August 01, 2011

Authors

Terumi Kamisawa1, Suresh T Chari, Samuel A Giday, Myung-Hwan Kim, Jae Bock Chung, Kyu Taek Lee, Jens Werner, Frank Bergmann, Markus M Lerch, Julia Mayerle, Tilman Pickartz, Matthias Lohr, Alexander Schneider, Luca Frulloni, George J M Webster, D Nageshwar Reddy, Wei-Chih Liao, Hsiu-Po Wang, Kazuichi Okazaki, Tooru Shimosegawa, Guenter Kloeppel, Vay Liang W Go

Author Affiliations

1: Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan. kamisawa@cick.jp

Articles citing this

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70

Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol (2014) 1.11

Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis. J Gastroenterol (2014) 1.02

Recent advances in autoimmune pancreatitis. Front Physiol (2012) 0.92

Pathophysiology of autoimmune pancreatitis. World J Gastrointest Pathophysiol (2014) 0.88

Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis. United European Gastroenterol J (2013) 0.87

Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87

Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver (2013) 0.86

Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterol J (2013) 0.84

Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis. World J Gastroenterol (2013) 0.83

IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J (2014) 0.83

A case of pancreatic cancer in the setting of autoimmune pancreatitis with nondiagnostic serum markers. Case Rep Surg (2013) 0.83

Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features. Cent Eur J Immunol (2014) 0.81

Role of endoscopic ultrasound in idiopathic acute pancreatitis with negative ultrasound, computed tomography, and magnetic resonance cholangiopancreatography. Ann Gastroenterol (2012) 0.81

Diagnosis of autoimmune pancreatitis. World J Gastroenterol (2014) 0.81

Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology (2016) 0.80

Endoscopic ultrasound-guided fine needle aspiration in the differentiation of type 1 and type 2 autoimmune pancreatitis. World J Gastroenterol (2012) 0.80

Treatment of autoimmune pancreatitis with the anecdotes of the first report. Int J Rheumatol (2012) 0.79

Endoscopic retrograde pancreatography: When should we do it? World J Gastrointest Endosc (2015) 0.79

Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review. PLoS One (2015) 0.79

Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis. Clin Transl Gastroenterol (2017) 0.78

Capability and limitations of recent diagnostic criteria for autoimmune pancreatitis. Int J Rheumatol (2013) 0.78

Autoimmune Pancreatitis and IgG4 Related Disease in Three Children. ACG Case Rep J (2016) 0.77

Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol (2013) 0.77

Autoimmune Pancreatitis: A Case of Atypical Radiographic Findings. Case Rep Gastroenterol (2016) 0.75

Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids. Orphanet J Rare Dis (2016) 0.75

Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract (2017) 0.75

Ulcerative colitis and immunoglobulin G4. Gut Liver (2013) 0.75

Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World J Gastroenterol (2017) 0.75

Autoimmune pancreatitis. Gland Surg (2016) 0.75

Clinical and Immunopathologic Profile of Mexican Patients with IgG4 Autoimmune Pancreatitis. ISRN Rheumatol (2012) 0.75

Autoimmune pancreatitis and cholangitis. World J Gastrointest Pharmacol Ther (2015) 0.75

From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract (2017) 0.75

Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75

Maintenance therapy in autoimmune pancreatitis: a weak light into the darkness. Ann Transl Med (2017) 0.75

[IgG4-associated diseases : State of the art]. Radiologe (2016) 0.75

[Hepatopancreaticobiliary diseases in IgG4-associated autoimmune diseases]. Radiologe (2016) 0.75

Diagnosis and Management of Autoimmune Pancreatitis. Curr Treat Options Gastroenterol (2017) 0.75

Articles by these authors

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr (2004) 9.01

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39

Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65

Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg (2012) 5.55

Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (2012) 4.62

International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56

Cohort profile: the study of health in Pomerania. Int J Epidemiol (2010) 4.38

Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26

IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet (2011) 3.45

Tracheal rapid ultrasound exam (T.R.U.E.) for confirming endotracheal tube placement during emergency intubation. Resuscitation (2011) 3.34

Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18

Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15

Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology (2010) 3.11

Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04

Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch (2004) 3.04

Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA (2012) 2.88

Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol (2004) 2.82

Most pancreatic cancer resections are R1 resections. Ann Surg Oncol (2008) 2.79

Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73

Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology (2002) 2.71

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol (2014) 2.64

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. Lancet Oncol (2013) 2.58

Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58

The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56

Autoimmune chronic pancreatitis. Am J Gastroenterol (2004) 2.53

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology (2007) 2.42

Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA (2002) 2.38

Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis (2007) 2.36

Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest (2002) 2.33

Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol (2008) 2.31

Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30

Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29

Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment. Gut (2013) 2.28

A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet (2009) 2.26

Enhanced expression of long non-coding RNA HOTAIR is associated with the development of gastric cancer. PLoS One (2013) 2.26

Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25

Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis (2012) 2.25

Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients. Pancreas (2008) 2.24

TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 2.23

Capsule endoscopy in obscure gastrointestinal bleeding--an Indian experience. Indian J Gastroenterol (2006) 2.21

Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med (2008) 2.18

Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol (2011) 2.17

Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol (2007) 2.15

Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14

A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut (2006) 2.14

The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol (2004) 2.14

Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol (2004) 2.12

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11

Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol (2013) 2.11

Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10

The prospective randomized, controlled trial of endoscopic ultrasound-guided fine-needle aspiration using 22G and 19G aspiration needles for solid pancreatic or peripancreatic masses. Am J Gastroenterol (2010) 2.09

Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res (2003) 2.08

Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas (2008) 2.07

Can endoscopic resection be applied for early stage ampulla of Vater cancer? Gastrointest Endosc (2006) 2.06

Prospective evaluation of subjects with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol (2012) 2.06

Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video). Gastrointest Endosc (2013) 2.06

The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets (2010) 2.05

Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer (2004) 2.05

Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat Genet (2005) 2.04

Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg (2008) 2.04

The impact of colon preparation timing on colonoscopic detection of colorectal neoplasms--a prospective endoscopist-blinded randomized trial. Am J Gastroenterol (2006) 2.03

Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood (2012) 2.03

Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02